241 related articles for article (PubMed ID: 17401217)
21. MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.
Davison JM; Ellis ST; Foxwell TJ; Luketich JD; Gibson MK; Kuan SF; Nason KS
Hum Pathol; 2014 Mar; 45(3):540-8. PubMed ID: 24290360
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus.
Labouvie C; Machado JC; Carneiro F; Sarbia M; Vieth M; Porschen R; Seitz G; Blin N
J Cancer Res Clin Oncol; 1999; 125(2):71-6. PubMed ID: 10190312
[TBL] [Abstract][Full Text] [Related]
23. [Histochemical diagnosis of short segment Barrett's esophagus].
Fujiyama Y; Ishizuka I; Koyama S
Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
[TBL] [Abstract][Full Text] [Related]
24. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.
Turner JR; Odze RD; Crum CP; Resnick MB
Hum Pathol; 1997 Jun; 28(6):740-4. PubMed ID: 9191010
[TBL] [Abstract][Full Text] [Related]
25. Mucin pattern reflects the origin of the adenocarcinoma in Barrett's esophagus: a retrospective clinical and laboratorial study.
Szachnowicz S; Cecconello I; Ribeiro U; Iriya K; El Ibrahim R; Takeda FR; Corbett CE; Vaz Safatle-Ribeiro A
World J Surg Oncol; 2009 Mar; 7():27. PubMed ID: 19272137
[TBL] [Abstract][Full Text] [Related]
26. Foveolar type dysplasia in Barrett esophagus.
Brown IS; Whiteman DC; Lauwers GY
Mod Pathol; 2010 Jun; 23(6):834-43. PubMed ID: 20228780
[TBL] [Abstract][Full Text] [Related]
27. Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2.
Van De Bovenkamp JH; Korteland-Van Male AM; Warson C; Büller HA; Einerhand AW; Ectors NL; Dekker J
Histopathology; 2003 Jun; 42(6):555-65. PubMed ID: 12786891
[TBL] [Abstract][Full Text] [Related]
28. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
29. Mucin Expression in the Esophageal Malignant and Pre-malignant States: A Systematic Review and Meta-analysis.
Niv Y; Ho SB; Fass R; Rokkas T
J Clin Gastroenterol; 2018 Feb; 52(2):91-96. PubMed ID: 28697153
[TBL] [Abstract][Full Text] [Related]
30. Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach.
Glickman JN; Shahsafaei A; Odze RD
Am J Surg Pathol; 2003 Oct; 27(10):1357-65. PubMed ID: 14508397
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan.
Azuma N; Endo T; Arimura Y; Motoya S; Itoh F; Hinoda Y; Irimura T; Hosokawa M; Imai K
J Gastroenterol; 2000; 35(8):583-92. PubMed ID: 10955596
[TBL] [Abstract][Full Text] [Related]
32. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
Phillips RW; Frierson HF; Moskaluk CA
Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
[TBL] [Abstract][Full Text] [Related]
33. c-Myc overexpression is strongly associated with metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
Schmidt MK; Meurer L; Volkweis BS; Edelweiss MI; Schirmer CC; Kruel CD; Gurski RR
Dis Esophagus; 2007; 20(3):212-6. PubMed ID: 17509117
[TBL] [Abstract][Full Text] [Related]
34. The role of mucin in GERD and its complications.
Niv Y; Fass R
Nat Rev Gastroenterol Hepatol; 2011 Nov; 9(1):55-9. PubMed ID: 22064520
[TBL] [Abstract][Full Text] [Related]
35. Gastric and intestinal differentiation in Barrett's metaplasia and associated adenocarcinoma.
Chaves P; Cruz C; Dias Pereira A; Suspiro A; de Almeida JC; Leitão CN; Soares J
Dis Esophagus; 2005; 18(6):383-7. PubMed ID: 16336609
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases.
Kazeminezhad B; Mirafsharieh SA; Dinyari K; Azizi D; Ebrahimi A
Turk J Gastroenterol; 2014 Jun; 25(3):253-6. PubMed ID: 25141312
[TBL] [Abstract][Full Text] [Related]
37. MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio.
Bax DA; Haringsma J; Einerhand AW; van Dekken H; Blok P; Siersema PD; Kuipers EJ; Kusters JG
J Clin Pathol; 2004 Dec; 57(12):1267-72. PubMed ID: 15563666
[TBL] [Abstract][Full Text] [Related]
38. Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns.
López-Ferrer A; Curull V; Barranco C; Garrido M; Lloreta J; Real FX; de Bolós C
Am J Respir Cell Mol Biol; 2001 Jan; 24(1):22-29. PubMed ID: 11152646
[TBL] [Abstract][Full Text] [Related]
39. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):613-21. PubMed ID: 23573307
[TBL] [Abstract][Full Text] [Related]
40. Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.
Dzinic SH; Mahdi Z; Bernardo MM; Vranic S; Beydoun H; Nahra N; Alijagic A; Harajli D; Pang A; Saliganan DM; Rahman AM; Skenderi F; Hasanbegovic B; Dyson G; Beydoun R; Sheng S
PLoS One; 2019; 14(4):e0215089. PubMed ID: 31002675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
